全球生物技术培养基、血清和试剂市场

全球生物技术培养基、血清和试剂市场预计将从 2024 年的 63 亿美元成长到 2029年终的 93 亿美元，预测期内的复合年增长率为 8.1%。

预计北美市场规模将从 2024 年的 23 亿美元成长到 2029年终的35 亿美元，预测期内的复合年增长率为 8.4%。预计欧洲市场规模将从 2024 年的 18 亿美元成长到 2029年终的 25 亿美元，复合年增长率为 7.4%。

本报告调查了全球生物技术培养基、血清和试剂市场，并提供了市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局以及主要企业的概况。

目录

第一章执行摘要

• 市场展望
• 研究范围
• 市场分析

第二章 市场概况

• 细胞培养类型
• 原代培养
• 次级培养
• 培养基基本成分
• 缓衝系统
• 酚红
• 无机盐
• 胺基酸
• 碳水化合物
• 蛋白质和胜肽
• 脂肪酸和脂质
• 维他命
• 微量元素
• 媒体增刊
• 抗生素
• 血清
• 细胞培养应用

第三章 市场动态

• 市场动态：概览
• 市场驱动因素
• 增加对生物製药的投资
• 个人化医疗需求日益增长
• 技术进步
• 人口老化和慢性病日益严重
• 市场限制
• 道德问题和监管限制
• 技能人才短缺和生物製药开发高成本
• 市场机会
• 3D 细胞培养需求不断成长
• 新兴国家对生物製药的需求不断增加

第 4 章 新兴技术

• 新兴技术
• AI/ML在细胞培养的应用
• 免洗技术
• 专利分析
• 细胞培养基
• 细胞培养试剂

第五章 监管情景

• 全球市场的监管状况
• 细胞培养基
• 血清

第六章市场区隔分析

• 全球市场洞察
• 细分市场
• 按产品类型进行的市场分析
• 试剂
• 培养基
• 血清
• 最终用户的市场分析
• 生物製药公司
• 学术研究所
• CDMO/CRO
• 其他的
• 地理分布
• 市场分析：按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第七章 竞争讯息

• 概述
• 市场排名分析
• 策略倡议
• 併购活动
• 投资与扩张
• 产品介绍

第 8 章 生物技术培养基、血清和试剂市场的永续性：ESG 视角

• ESG：简介
• ESG永续性趋势与倡议
• 环境倡议
• 社会与管治倡议
• 管治倡议
• ESG风险评估分析
• BCC的结语

第 9 章 附录

• 调查方法
• 来源
• 简称
• 公司简介
• ATCC
• BD
• BIO-TECHNE
• BIOWEST
• CORNING INC.
• DANAHER CORP.
• FUJIFILM IRVINE SCIENTIFIC
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROMOCELL GMBH
• REPROCELL INC.
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.

The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.

The North American market for media, sera and reagents in biotechnology is expected to grow from $2.3 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 8.4% during the forecast period of 2024 to 2029.

The European market for media, sera and reagents in biotechnology is expected to grow from $1.8 billion in 2024 and is projected to reach $2.5 billion by the end of 2029, at a CAGR of 7.4% during the forecast period of 2024 to 2029.

Report Scope

This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition. The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.

Report Includes

• 87 data tables and 55 additional tables
• An analysis of the global market for media, sera and reagents in the biotech industry
• Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the overall market size for media, sera and reagents and their corresponding market share analysis by product type, end use and region
• Discussion of the market potential, and forecasts for the market's segments and sub-segments
• In-depth information concerning market drivers, opportunities, challenges and other demographic and economic factors that will drive demand for media, sera and reagents
• Review of the current market status, key technology issues, industry value chain, Porter's Five Forces, competitive landscape and R&D activity
• A discussion of the industry's ESG challenges and practices
• Market share analysis of the key companies in the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies
• Profiles of the leading companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Insights

Chapter 2 Market Overview

• Introduction
• Types of Cell Culture
• Primary Culture
• Secondary Culture
• Basic Components of Culture Media
• Buffering Systems
• Phenol Red
• Inorganic Salts
• Amino Acids
• Carbohydrates
• Proteins and Peptides
• Fatty Acids and Lipids
• Vitamins
• Trace Elements
• Media Supplements
• Antibiotics
• Serum
• Cell Culture Applications

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Rising Investments in Biopharmaceuticals
• Increasing Demand for Personalized Medicines
• Technological Advances
• Rising Aging Population and the Growing Prevalence of Chronic Diseases
• Market Restraints
• Ethical Issues and Regulatory Constraints
• Lack of Skilled Professionals and High Cost of Biopharmaceutical Development
• Market Opportunities
• Rising Demand for 3D Cell Cultures
• Rising Demand for Biopharmaceuticals in Emerging Countries

Chapter 4 Emerging Technologies

• Introduction
• Emerging Technologies
• Application of AI/ML in Cell Culture
• Single Use Technologies
• Patent Analysis
• Cell Culture Media
• Cell Culture Reagents

Chapter 5 Regulatory Scenario

• Regulatory Landscape in the Global Market
• Cell Culture Media
• Sera

Chapter 6 Market Segmentation Analysis

• Global Market Insights
• Segmentation Breakdown
• Market Analysis by Product Type
• Reagents
• Media
• Sera
• Market Analysis by End User
• Biopharmaceutical Companies
• Academic Research Institutes
• Contract Manufacturing and Development Organizations (CDMOs/CROs)
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Overview
• Market Rankings Analysis
• Strategic Initiatives
• M&A Activities
• Investments and Expansions
• Product Introductions

Chapter 8 Sustainability in the Media, Sera and Reagents in Biotechnology Market: An ESG Perspective

• Introduction to ESG
• ESG Sustainability Trends and Initiatives
• Environmental Initiatives
• Social and Governance Initiatives
• Governance Initiatives
• ESG Risk Ratings Analysis
• Concluding Remarks from BCC

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ATCC
• BD
• BIO-TECHNE
• BIOWEST
• CORNING INC.
• DANAHER CORP.
• FUJIFILM IRVINE SCIENTIFIC
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROMOCELL GMBH
• REPROCELL INC.
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2029
• Table 1 : Primary Versus Continuous Cell Lines
• Table 2 : Medicines in Development, by Select Disease Category, 2020
• Table 3 : Incidence and Mortality Rates of Cancer Across Regions, 2022
• Table 4 : Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 5 : Global Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 6 : Global Market for Cell Culture Reagents, by Region, Through 2029
• Table 7 : Global Market for Cell Culture Media, by Region, Through 2029
• Table 8 : Global Market for Cell Culture Media, by Sera, Through 2029
• Table 9 : Global Market for Cell Culture Media, by Formulation, Through 2029
• Table 10 : Global Market for Cell Culture Media, by Composition, Through 2029
• Table 11 : Global Market for Cell Culture Sera, by Region, Through 2029
• Table 12 : Global Market for Cell Culture Sera, by Type, Through 2029
• Table 13 : Global Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 14 : Global Market for Media, Sera and Reagents Use in Biopharmaceutical Companies, by Region, Through 2029
• Table 15 : Global Market for Media, Sera and Reagents Use in Academic Research Institutes, by Region, Through 2029
• Table 16 : Global Market for Media, Sera and Reagents Use in CDMOs/CROs, by Region, Through 2029
• Table 17 : Global Market for Media, Sera and Reagents in Other End Uses, by Region, Through 2029
• Table 18 : Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2029
• Table 19 : North American Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029
• Table 20 : North American Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 21 : North American Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 22 : North American Market for Cell Culture Media, by Sera, Through 2029
• Table 23 : North American Market for Cell Culture Media, by Formulation, Through 2029
• Table 24 : North American Market for Cell Culture Media, by Composition, Through 2029
• Table 25 : North American Market for Cell Culture Sera, by Type, Through 2029
• Table 26 : North American Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 27 : The U.S. Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 28 : The U.S. Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 29 : Canadian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 30 : Canadian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 31 : Mexican Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 32 : Mexican Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 33 : European-Based Companies' R&D Expenditures and Comparison of Their Net Sales, 2023
• Table 34 : European Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029
• Table 35 : European Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 36 : European Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 37 : European Market for Cell Culture Media, by Sera, Through 2029
• Table 38 : European Market for Cell Culture Media, by Formulation, Through 2029
• Table 39 : European Market for Cell Culture Media, by Composition, Through 2029
• Table 40 : European Market for Cell Culture Sera, by Type, Through 2029
• Table 41 : European Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 42 : German Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 43 : German Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 44 : French Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 45 : French Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 46 : Italian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 47 : Italian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 48 : Spanish Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 49 : Spanish Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 50 : The U.K. Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 51 : The U.K. Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 52 : Rest of European Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 53 : Rest of European Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 54 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029
• Table 55 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 56 : Asia-Pacific Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 57 : Asia-Pacific Market for Cell Culture Media, by Sera, Through 2029
• Table 58 : Asia-Pacific Market for Cell Culture Media, by Formulation, Through 2029
• Table 59 : Asia-Pacific Market for Cell Culture Media, by Composition, Through 2029
• Table 60 : Asia-Pacific Market for Cell Culture Sera, by Type, Through 2029
• Table 61 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 62 : Chinese Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 63 : Chinese Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 64 : Japanese Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 65 : Japanese Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 66 : Indian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 67 : Indian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 68 : South Korean Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 69 : South Korean Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 70 : Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 71 : Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 72 : RoW Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 73 : RoW Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 74 : RoW Market for Cell Culture Media, by Sera, Through 2029
• Table 75 : RoW Market for Cell Culture Media, by Formulation, Through 2029
• Table 76 : RoW Market for Cell Culture Media, by Composition, Through 2029
• Table 77 : RoW Market for Cell Culture Sera, by Type, Through 2029
• Table 78 : RoW Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 79 : Global Ranking of Manufacturers in Media, Sera and Reagents Market, 2023
• Table 80 : Partnerships, Agreements and Collaborations in Media, Sera and Reagents in the Biotechnology Industry, 2021-2025
• Table 81 : Merger and Acquisition Activities in Media, Sera and Reagents in the Biotechnology Market, 2022-2024
• Table 82 : Recent Investment and Expansion Activities in Media, Sera and Reagents in the Biotechnology Market, 2022-2024
• Table 83 : Recent Product Innovations in the Cell Culture Media, Sera and Reagents Market, 2021-2024
• Table 84 : Environmental Initiatives by Various Suppliers of Media, Sera and Reagents in the Biotechnology Market
• Table 85 : Key Social and Governance Issues in the Media, Sera and Reagents Biotechnology Market
• Table 86 : ESG Risk Ratings for Companies in the Media, Sera and Reagents Market, 2023
• Table 87 : Information Sources for this Report
• Table 88 : Abbreviations Used in the Media, Sera and Reagents in Biotechnology Market
• Table 89 : ATCC: Company Snapshot
• Table 90 : ATCC: Product Portfolio
• Table 91 : ATCC: News/Key Developments, 2023 and 2024
• Table 92 : BD: Company Snapshot
• Table 93 : BD: Financial Performance, FY 2023 and 2024
• Table 94 : BD: Product Portfolio
• Table 95 : BD: News/Key Developments, 2022-2024
• Table 96 : Bio-Techne: Company Snapshot
• Table 97 : Bio-Techne: Financial Performance, FY 2022 and 2023
• Table 98 : Bio-Techne: Product Portfolio
• Table 99 : Bio-Techne: News/Key Developments, 2021-2024
• Table 100 : Biowest.: Company Snapshot
• Table 101 : Biowest: Product Portfolio
• Table 102 : Corning Inc.: Company Snapshot
• Table 103 : Corning Inc.: Financial Performance, FY 2022 and 2023
• Table 104 : Corning Inc.: Product Portfolio
• Table 105 : Corning Inc.: News/Key Developments, 2022 and 2023
• Table 106 : Danaher Corp.: Company Snapshot
• Table 107 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 108 : Danaher Corp.: Product Portfolio
• Table 109 : Danaher Corp.: News/Key Developments, 2021-2023
• Table 110 : Fujifilm Irvine Scientific: Company Snapshot
• Table 111 : Fujifilm Irvine Scientific: Product Portfolio
• Table 112 : Fujifilm Irvine Scientific: News/Key Developments, 2022-2024
• Table 113 : Lonza: Company Snapshot
• Table 114 : Lonza: Financial Performance, FY 2022 and 2023
• Table 115 : Lonza: Product Portfolio
• Table 116 : Lonza: News/Key Developments, 2023 and 2024
• Table 117 : Merck KGaA: Company Snapshot
• Table 118 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 119 : Merck KGaA.: Product Portfolio
• Table 120 : Merck KGaA: News/Key Developments, 2021-2025
• Table 121 : Miltenyi Biotec: Company Snapshot
• Table 122 : Miltenyi Biotec: Product Portfolio
• Table 123 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
• Table 124 : PromoCell GmbH.: Company Snapshot
• Table 125 : PromoCell GmbH.: Product Portfolio
• Table 126 : PromoCell GmbH.: News/Key Developments, 2023 and 2024
• Table 127 : REPROCELL Inc.: Company Snapshot
• Table 128 : REPROCELL Inc.: Financial Performance, FY 2022 and 2023
• Table 129 : REPROCELL Inc.: Product Portfolio
• Table 130 : REPROCELL Inc.: News/Key Developments, 2021-2025
• Table 131 : Sartorius AG: Company Snapshot
• Table 132 : Sartorius AG: Financial Performance, FY 2022 and 2023
• Table 133 : Sartorius AG: Product Portfolio
• Table 134 : Sartorius AG: News/Key Developments, 2023 and 2024
• Table 135 : STEMCELL Technologies: Company Snapshot
• Table 136 : STEMCELL Technologies: Product Portfolio
• Table 137 : STEMCELL Technologies: News/Key Developments, 2021-2024
• Table 138 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 139 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 140 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 141 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

• Summary Figure : Global Market for Media, Sera and Reagents in Biotechnology, by Region, 2021-2029
• Figure 1 : Cell Culture Timeline
• Figure 2 : Market Dynamics of Global Media, Sera and Reagents in Biotechnology
• Figure 3 : Venture Averages for Biopharma Therapeutics and Platform Companies, 2010-2024
• Figure 4 : Personalized Medicines' Contribution to the Total FDA Approvals, 2015-2023
• Figure 5 : Patents Documented on Cell Culture Media, by Top Applicants, 2021-January, 2025
• Figure 6 : Share of Patents on Cell Culture Media, by Patent Jurisdiction, 2021-January 2025
• Figure 7 : Patents Documented on Cell Culture Media Over Time, 2010-January 2025
• Figure 8 : Patents Documented on Cell Culture Reagents, by Top Applicants, 2021-January 2025
• Figure 9 : Share of Patents on Cell Culture Reagents, by Jurisdiction, 2021-January 2025
• Figure 10 : Patents Documented on Cell Culture Reagents Over Time, 2010-January 2025
• Figure 11 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Product Type, 2023
• Figure 12 : Global Market Shares of Cell Culture Reagents, by Reagent Type, 2023
• Figure 13 : Global Market Shares of Cell Culture Media, by Sera, 2023
• Figure 14 : Global Market Shares of Cell Culture Media, by Formulation, 2023
• Figure 15 : Global Market Shares of Cell Culture Media, by Composition, 2023
• Figure 16 : Global Market Shares of Cell Culture Sera, by Type, 2023
• Figure 17 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by End User, 2023
• Figure 18 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Region, 2023
• Figure 19 : North American Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023
• Figure 20 : The U.S. NIH Funding in Healthcare Research and Development Activities, 2010-2023
• Figure 21 : Number of Novel Drug Approvals by U.S. FDA, by Drug Biologic Type, 2020-2024
• Figure 22 : European Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023
• Figure 23 : Asia-Pacific Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023
• Figure 24 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Manufacturer/Supplier, 2023
• Figure 25 : Advantages of ESG for the Companies in Cell Culture Media, Sera and Reagents
• Figure 26 : BD: Revenue Shares, by Business Unit, FY 2024
• Figure 27 : BD: Revenue Shares, by Country/Region, FY 2024
• Figure 28 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023
• Figure 29 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023
• Figure 30 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 31 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 32 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
• Figure 33 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
• Figure 34 : Lonza: Revenue Shares, by Business Unit, FY 2023
• Figure 35 : Lonza: Revenue Shares, by Country/Region, FY 2023
• Figure 36 : Merck KGaA: Revenue Shares, by Business Unit, FY 2023
• Figure 37 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
• Figure 38 : REPROCELL Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 39 : REPROCELL Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 40 : Sartorius AG: Revenue Shares, by Business Unit, FY 2023
• Figure 41 : Sartorius AG: Revenue Shares, by Country/Region, FY 2023
• Figure 42 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023